In terms of temporal tumor heterogeneity, patients with heterogeneous HER2 status between primary and metastatic disease showed higher HI-inter value (z = −2.289; p = 0.022) and similar HI-intra value (z = −0.785, p = 0.432). Here, ERBB2 is linked to metastatic neoplasm.